Form 4: Vaxart SVP Sean Tucker Reports Changes in Beneficial Ownership

Sean Tucker, SVP and Chief Scientific Officer of Vaxart, Inc., reports changes in beneficial ownership of company stock due to tax withholding upon RSU vesting.

Summary

• Sean Tucker, SVP and Chief Scientific Officer of Vaxart, Inc., filed a Form 4 with the SEC on April 1, 2024.
• The filing reports changes in Mr. Tucker's beneficial ownership of Vaxart common stock.
• On March 28, 2024, 3,902 shares were withheld by Vaxart to satisfy income tax obligations related to the vesting of Restricted Stock Units (RSUs).
• Following the transaction, Mr. Tucker directly owns 355,695 shares of Vaxart common stock.
• He also indirectly owns 51,465 shares through joint tenancy with Frances Chang and Sean Tucker, and 9,060 shares through his spouse.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing regarding stock ownership changes due to tax withholding, which has a neutral sentiment.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Stakeholder Impact

• The change in ownership is minimal and unlikely to significantly impact shareholders.

Key Dates